Published in J Allergy Clin Immunol on November 08, 2012
The crucial task of defining a healthy immune response toward respiratory infections. J Allergy Clin Immunol (2013) 1.07
Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respir Res (2013) 0.97
Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin Transl Med (2015) 0.95
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function. Int J Chron Obstruct Pulmon Dis (2015) 0.85
Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae. PLoS One (2014) 0.84
The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi). J Immunol Res (2015) 0.83
Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. Br J Clin Pharmacol (2015) 0.82
Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression. PLoS One (2015) 0.80
Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children. Front Pediatr (2015) 0.78
Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells. Respir Res (2016) 0.76
Insights on Persistent Airway Infection by Nontypeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease. Pathog Dis (2017) 0.75
Reply: To PMID 23142009. J Allergy Clin Immunol (2013) 0.75
Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nat Commun (2017) 0.75
Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int (2012) 2.47
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39
CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement. Med J Aust (2010) 2.34
Abnormal vocal cord function in difficult-to-treat asthma. Am J Respir Crit Care Med (2011) 2.27
Carbon dioxide insufflation in open-chamber cardiac surgery: a double-blind, randomized clinical trial of neurocognitive effects. J Thorac Cardiovasc Surg (2012) 2.04
Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol (2010) 2.03
Laryngeal penetration and aspiration in individuals with stable COPD. Respirology (2011) 1.95
Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med (2002) 1.83
Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg (2009) 1.69
The Th17-defining transcription factor RORγt promotes glomerulonephritis. J Am Soc Nephrol (2010) 1.67
Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust (2010) 1.66
IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol (2009) 1.62
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv (2009) 1.61
Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis (2002) 1.59
Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol (2009) 1.55
Microbiologic follow-up study in adult bronchiectasis. Respir Med (2007) 1.52
Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol (2006) 1.49
Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis. J Am Soc Nephrol (2012) 1.49
T cells in crescentic glomerulonephritis. J Am Soc Nephrol (2006) 1.45
Allergy is an important factor in asthma exacerbation: a pro/con debate. Respirology (2010) 1.41
Abnormal vocal cord movement treated with botulinum toxin in patients with asthma resistant to optimised management. Respirology (2014) 1.38
Urgent and emergency coronary artery bypass grafting for acute coronary syndromes. ANZ J Surg (2006) 1.37
Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.22
T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2008) 1.20
IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment. J Am Soc Nephrol (2005) 1.20
Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.19
Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int (2005) 1.18
Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. J Am Soc Nephrol (2004) 1.14
Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med (2006) 1.10
Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J Am Soc Nephrol (2007) 1.10
Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J Allergy Clin Immunol (2005) 1.06
Outcome in adult bronchiectasis. COPD (2005) 1.06
Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am J Pathol (2004) 1.06
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer. Thorax (2013) 1.03
Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. Arthritis Rheum (2011) 1.03
IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant (2009) 1.03
The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol (2011) 1.02
IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. J Immunol (2002) 1.02
Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.02
Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney Int (2011) 1.01
T cells in glomerulonephritis. Springer Semin Immunopathol (2003) 1.01
Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J Am Soc Nephrol (2004) 1.00
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer. Breast Cancer Res (2014) 0.98
Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. J Infect Dis (2003) 0.98
Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J Autoimmun (2008) 0.98
The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J Am Soc Nephrol (2002) 0.96
Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int (2010) 0.96
Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol (2011) 0.96
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci U S A (2012) 0.96
Perinatal evolution of mesenchymal hamartoma of the chest wall. J Pediatr Surg (2010) 0.96
Collecting data on quality is feasible in community-based palliative care. J Pain Symptom Manage (2011) 0.95
A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2005) 0.95
An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity. J Immunol (2004) 0.94
CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms. Kidney Int (2005) 0.94
Palliative care needs of patients with cancer living in the community. J Oncol Pract (2011) 0.94
Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function. Blood (2013) 0.94
Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. J Am Soc Nephrol (2005) 0.94
Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg (2004) 0.93
Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses. Am J Respir Cell Mol Biol (2009) 0.93
CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis. J Immunol (2006) 0.93
Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue. J Thorac Cardiovasc Surg (2005) 0.93
Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood. COPD (2009) 0.92
Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int (2011) 0.91
Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. J Am Soc Nephrol (2005) 0.90
The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease. J Immunol Methods (2005) 0.90
Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. JACC Cardiovasc Interv (2008) 0.90
Diagnosis of vocal cord dysfunction in asthma with high resolution dynamic volume computerized tomography of the larynx. Respirology (2009) 0.90
Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J Med Virol (2005) 0.90
Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. Am J Pathol (2010) 0.90
The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN. J Am Soc Nephrol (2013) 0.89
Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cells. J Am Soc Nephrol (2008) 0.89
Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis. Immunology (2008) 0.89
Mast cells mediate acute kidney injury through the production of TNF. J Am Soc Nephrol (2011) 0.89
Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Catheter Cardiovasc Interv (2005) 0.89
Laboratory assessment of immune function in renal transplant patients. Nephrol Dial Transplant (2003) 0.88
Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. Respiration (2002) 0.88
Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Catheter Cardiovasc Interv (2008) 0.88
Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis. J Am Soc Nephrol (2006) 0.87
Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol (2011) 0.87
Review: T helper 17 cells: their role in glomerulonephritis. Nephrology (Carlton) (2010) 0.87
The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. Am J Pathol (2011) 0.86
Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. Immunology (2009) 0.86
Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosis. Am J Pathol (2011) 0.86
Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am J Pathol (2011) 0.86
Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells. PLoS One (2013) 0.85
Use of antibiotics in bronchiectasis. Rev Recent Clin Trials (2012) 0.85
Fast-track cardiac surgery: application in an Australian setting. Asian Cardiovasc Thorac Ann (2007) 0.85
Lobar torsion following bilateral lung transplantation. J Card Surg (2014) 0.85
Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. Cell Immunol (2013) 0.85
A reinforced sternal wiring technique for transverse thoracosternotomy closure in bilateral lung transplantation: from biomechanical test to clinical application. J Thorac Cardiovasc Surg (2007) 0.84
Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice. Am J Physiol Lung Cell Mol Physiol (2012) 0.84
Dual-energy X-ray absorptiometry is the method of choice to assess body composition in COPD. Respirology (2009) 0.84
Vascular endothelial growth factor induction by rhinovirus infection. J Med Virol (2006) 0.83
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia. J Med Microbiol (2010) 0.83